The DOI matches its Crossref record; 103 of the 104 references it cites were found in a registry or an index.
Hypoxia signalling in cancer and approaches to enforce tumour regression
Abstract
Tumour cells emerge as a result of genetic alteration of signal circuitries promoting cell growth and survival, whereas their expansion relies on nutrient supply. Oxygen limitation is central in controlling neovascularization, glucose metabolism, survival and tumour spread. This pleiotropic action is orchestrated by hypoxia-inducible factor (HIF), which is a master transcriptional factor in nutrient stress signalling. Understanding the role of HIF in intracellular pH (pH(i)) regulation, metabolism, cell invasion, autophagy and cell death is crucial for developing novel anticancer therapies. There are new approaches to enforce necrotic cell death and tumour regression by targeting tumour metabolism and pH(i)-control systems.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The affinity of PHDs and FIH-1 for oxygen differs and, since FIH-1 has a higher affinity (lower K m ) for oxygen, PHDs are thought to be more rapidly inhibited in low oxygen conditions (Pouyssegur et al., 2006).”
From Therapeutic targeting of hypoxia and hypoxia-inducible factors in cancer (2016) · cites this paper as Pouyssegur et al., 2006
In the citing paper
“this is recognized to have profound effects on the tumor metabolism (92)(93)(94)”
From Adipose tissue remodeling and obesity (2011) · cites this paper as [93]
In the citing paper
“O 2 tension in the center of solid tumors may be so low that cells essentially become anoxic”
From Adipose tissue remodeling and obesity (2011) · cites this paper as [93]
Citations
Cites
1 retracted
Lysyl oxidase is essential for hypoxia-induced metastasis
Erler, J. T., Bennewith, K. L., Nicolau, M., Dornhöfer, N., Kong, C., Le, Q.-T., Chi, J.-T. A., Jeffrey, S. S., & Giaccia, A. J. (2006) · Nature · doi:10.1038/nature04695 · Cited by 1,309
RetractedThe biology of VEGF and its receptors
Ferrara, N., Gerber, H.-P., & LeCouter, J. (2003) · Nature Medicine · doi:10.1038/nm0603-669 · Cited by 9,591
Targeting HIF-1 for cancer therapy
Semenza, G. L. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1187 · Cited by 6,717
Jaakkola, P., Mole, D. R., Tian, Y.-M., Wilson, M. I., Gielbert, J., Gaskell, S. J., Kriegsheim, A. V., Hebestreit, H. F., Mukherji, M., Schofield, C. J., et al. (2001) · Science · doi:10.1126/science.1059796 · Cited by 5,535
Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene
Ferrara, N., Carver-Moore, K., Chen, H., Dowd, M., Lu, L., O’Shea, K. S., Powell-Braxton, L., Hillan, K. J., & Moore, M. W. (1996) · Nature · doi:10.1038/380439a0 · Cited by 3,661
Angiopoietin-2, a Natural Antagonist for Tie2 That Disrupts in vivo Angiogenesis
Maisonpierre, P. C., Suri, C., Jones, P. F., Bartunkova, S., Wiegand, S. J., Radziejewski, C., Compton, D., McClain, J., Aldrich, T. H., Papadopoulos, N., et al. (1997) · Science · doi:10.1126/science.277.5322.55 · Cited by 3,570
Epstein, A. C. R., Gleadle, J. M., McNeill, L. A., Hewitson, K. S., O'Rourke, J., Mole, D. R., Mukherji, M., Metzen, E., Wilson, M. I., Dhanda, A., et al. (2001) · Cell · doi:10.1016/s0092-8674(01)00507-4 · Cited by 3,333
VEGF guides angiogenic sprouting utilizing endothelial tip cell filopodia
Gerhardt, H., Golding, M., Fruttiger, M., Ruhrberg, C., Lundkvist, A., Abramsson, A., Jeltsch, M., Mitchell, C., Alitalo, K., Shima, D., et al. (2003) · The Journal of Cell Biology · doi:10.1083/jcb.200302047 · Cited by 2,894
Kahn, B. B., Alquier, T., Carling, D., & Hardie, D. G. (2005) · Cell Metabolism · doi:10.1016/j.cmet.2004.12.003 · Cited by 2,799
Angiogenesis as a therapeutic target
Ferrara, N., & Kerbel, R. S. (2005) · Nature · doi:10.1038/nature04483 · Cited by 2,653
Flagged first, then by citations
1 of the 104 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 601–700 of 1,002
Kreis, S., Munz, G. A., Haan, S., Heinrich, P. C., & Behrmann, I. (2007) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-07-0317 · Cited by 58
COMMD1 Promotes pVHL and O2-Independent Proteolysis of HIF-1α via HSP90/70
van de Sluis, B., Groot, A. J., Vermeulen, J. F., van der Wall, E., van Diest, P. J., Wijmenga, C., Klomp, L. W. J., & Vooijs, M. (2009) · PLoS ONE · doi:10.1371/journal.pone.0007332 · Cited by 56
Hypoxia-Induced Pulmonary Arterial Smooth Muscle Cell Proliferation Is Controlled by Forkhead Box M1
Raghavan, A., Zhou, G., Zhou, Q., Ibe, J. C. F., Ramchandran, R., Yang, Q., Racherla, H., Raychaudhuri, P., & Raj, J. U. (2011) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2011-0128oc · Cited by 56
Functional antibodies produced by oncolytic clostridia
Groot, A. J., Mengesha, A., van der Wall, E., van Diest, P. J., Theys, J., & Vooijs, M. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.10.126 · Cited by 56
Chia, J., Du, J.-L., Hsu, W.-B., Sun, A., Chiang, C., & Wang, W.-B. (2010) · BMC Cancer · doi:10.1186/1471-2407-10-175 · Cited by 56
Peralta-Leal, A., Rodríguez, M. I., & Oliver, F. J. (2008) · Clinical & Translational Oncology · doi:10.1007/s12094-008-0207-8 · Cited by 57
Jeon, H. W., & Lee, Y. M. (2010) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-09-0717 · Cited by 56
The regulation of transcriptional repression in hypoxia
Cavadas, M. A. S., Cheong, A., & Taylor, C. T. (2017) · Experimental Cell Research · doi:10.1016/j.yexcr.2017.02.024 · Cited by 55
Iikuni, S., Ono, M., Watanabe, H., Shimizu, Y., Sano, K., & Saji, H. (2018) · Theranostics · doi:10.7150/thno.20982 · Cited by 56
Annexins sense changes in intracellular pH during hypoxia
Monastyrskaya, K., Tschumi, F., Babiychuk, E. B., Stroka, D., & Draeger, A. (2007) · Biochemical Journal · doi:10.1042/bj20071116 · Cited by 56
Ladroue, C., Hoogewijs, D., Gad, S., Carcenac, R., Storti, F., Barrois, M., Gimenez-Roqueplo, A.-P., Leporrier, M., Casadevall, N., Hermine, O., et al. (2012) · Haematologica · doi:10.3324/haematol.2011.044644 · Cited by 55
Self-citationProliferating tumor cells mimick glucose metabolism of mature human erythrocytes
Ghashghaeinia, M., Köberle, M., Mrowietz, U., & Bernhardt, I. (2019) · Cell Cycle · doi:10.1080/15384101.2019.1618125 · Cited by 55
Adaptive and maladaptive roles of lipid droplets in health and disease
Pressly, J. D., Gurumani, M. Z., Santos, J. T. V., Fornoni, A., Merscher, S., & Al‐Ali, H. (2022) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00239.2021 · Cited by 54
Extracellular acidity strengthens mesenchymal stem cells to promote melanoma progression
Peppicelli, S., Bianchini, F., Toti, A., Laurenzana, A., Fibbi, G., & Calorini, L. (2015) · Cell Cycle · doi:10.1080/15384101.2015.1078032 · Cited by 59
Acidic pH via NF-κB favours VEGF-C expression in human melanoma cells
Peppicelli, S., Bianchini, F., Contena, C., Tombaccini, D., & Calorini, L. (2013) · Clinical & Experimental Metastasis · doi:10.1007/s10585-013-9595-4 · Cited by 55
Mao, X., Yan, M., Xue, X., Zhang, X., Ren, H.-G., Guo, G., Wang, P., Zhang, W., & Huo, J. (2011) · Laboratory Investigation · doi:10.1038/labinvest.2011.56 · Cited by 55
Spinella, F., Rosanò, L., Duca, M. D., Castro, V. D., Nicotra, M. R., Natali, P. G., & Bagnato, A. (2010) · PLoS ONE · doi:10.1371/journal.pone.0011241 · Cited by 55
RetractedSung, F. L., Hui, E. P., Tao, Q., Li, H., Tsui, N. B. Y., Lo, Y. M. D., Ma, B. B. Y., To, K. F., Harris, A. L., & Chan, A. T. �. (2007) · Cancer Letters · doi:10.1016/j.canlet.2007.01.012 · Cited by 55
Kim, J.-K., Shao, Y. X., Kim, S. Y., Kim, S., Song, H. K., Jeon, J. H., Suh, H., Chung, J. W., Yoon, S. R., Kim, Y. S., et al. (2007) · Molecular Biology of the Cell · doi:10.1091/mbc.e07-02-0182 · Cited by 56
Upregulation of Wnt signaling under hypoxia promotes lung cancer progression
Hong, C.-F., Chen, W.-Y., & Wu, C. (2017) · Oncology Reports · doi:10.3892/or.2017.5807 · Cited by 56
Current Advances on Nanomaterials Interfering with Lactate Metabolism for Tumor Therapy
Cheng, Q., Shi, X., Li, Q., Wang, L., & Wang, Z. (2023) · Advanced Science · doi:10.1002/advs.202305662 · Cited by 58
Powathil, G., Munro, A. J., Chaplain, M. A. J., & Swat, M. (2016) · Journal of Theoretical Biology · doi:10.1016/j.jtbi.2016.04.010 · Cited by 54
Hypoxia and HIFs in regulating the development of the hematopoietic system
Imanirad, P., & Dzierzak, E. A. (2013) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2013.08.005 · Cited by 54
Differential expression of microRNAs in ischemic heart disease
Song, M., Paradis, A. N., Gay, M. S., Shin, J. Y., & Zhang, L. (2014) · Drug Discovery Today · doi:10.1016/j.drudis.2014.10.004 · Cited by 53
Choi, H. J., Song, B. J., Gong, Y., Gwak, W. J., & Soh, Y. (2008) · British Journal of Pharmacology · doi:10.1038/bjp.2008.70 · Cited by 54
Janonienė, A., Liu, Z., Baranauskienė, L., Mäkilä, E. M., Ma, M., Salonen, J., Hirvonen, J. J., Zhang, H., Petrikaitė, V., & Santos, H. A. (2017) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.7b04038 · Cited by 54
Overexpression of PDK2 and PDK3 reflects poor prognosis in acute myeloid leukemia
Cui, L., Cheng, Z., Liu, Y., Dai, Y., Pang, Y., Jiao, Y., Ke, X., Cui, W., Zhang, Q., Shi, J., et al. (2018) · Cancer Gene Therapy · doi:10.1038/s41417-018-0071-9 · Cited by 54
Targeting autophagy in chemotherapy-resistant of hepatocellular carcinoma.
Sheng, J., Qin, H., Zhang, K., Li, B., & Zhang, X. (2018) · PubMed Central · Cited by 54
Rani, S., Roy, S., Singh, M., & Kaithwas, G. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/2407223 · Cited by 57
Placental Regulation of Inflammation and Hypoxia after TNF ‐α Infusion in Mice
Bobek, G., Surmon, L., Colafella, K. M. M., Makris, A., & Hennessy, A. (2015) · American Journal of Reproductive Immunology · doi:10.1111/aji.12417 · Cited by 53
An, H., Shin, H. J., Jo, S.-G., Kim, Y., Lee, J., Paik, S., & Lee, H. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2011.07.017 · Cited by 53
Ubiquitin/SUMO Modification Regulates VHL Protein Stability and Nucleocytoplasmic Localization
Cai, Q., & Robertson, E. S. (2010) · PLoS ONE · doi:10.1371/journal.pone.0012636 · Cited by 53
RetractedCirculating angiopoietin-2 and soluble Tie-2 in type 2 diabetes mellitus: a cross-sectional study
Rasul, S., Schernthaner-Reiter, M. H., İlhan, A., Lampichler, K., Wagner, L., & Kautzky‐Willer, A. (2011) · Cardiovascular Diabetology · doi:10.1186/1475-2840-10-55 · Cited by 53
Extracellular acidity as favouring factor of tumor progression and metastatic dissemination.
Calorini, L., Peppicelli, S., & Bianchini, F. (2012) · PubMed · Cited by 53
Kim, H. K., Lee, I.-K., Bang, H., Kim, H. C., Lee, W. Y., Yun, S. H., Lee, J., Lee, S. J., Park, Y. S., Kim, K., et al. (2018) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-17-0535 · Cited by 53
Huang, S., Qi, P., Zhang, T., Li, F., & He, X. (2018) · Oncology Reports · doi:10.3892/or.2018.6929 · Cited by 53
Nano versus Molecular: Optical Imaging Approaches to Detect and Monitor Tumor Hypoxia
Cheng, M. H. Y., Mo, Y., & Zheng, G. (2020) · Advanced Healthcare Materials · doi:10.1002/adhm.202001549 · Cited by 55
Luan, N., Mu, Y., Mu, J., Chen, Y., Ye, X., Zhou, Q., Xu, M., Deng, Q., Hu, Y., Tang, Z., et al. (2021) · Frontiers in Genetics · doi:10.3389/fgene.2021.638244 · Cited by 52
Oxygen control: the often overlooked but essential piece to create better in vitro systems
Palacio-Castañeda, V., Velthuijs, N., Gac, S. L., & Verdurmen, W. P. R. (2022) · Lab on a Chip · doi:10.1039/d1lc00603g · Cited by 54
On the Importance of Acidity in Cancer Cells and Therapy
Tafech, A., & Stéphanou, A. (2024) · Biology · doi:10.3390/biology13040225 · Cited by 52
Merscher, S., Pedigo, C. E., & Mendez, A. J. (2014) · Frontiers in Endocrinology · doi:10.3389/fendo.2014.00169 · Cited by 55
Ratcliffe, P. P., & Bishop, T. (2014) · Hypoxia · doi:10.2147/hp.s47598 · Cited by 55
Chen, J.-L., Lin, H. H., Kim, K., Lin, A., Forman, H. J., & Ann, D. K. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m804239200 · Cited by 52
Hou, X., Li, Y., Luo, R., Fu, J., He, J., Zhang, L., & Yang, H.-X. (2012) · European Journal of Surgical Oncology · doi:10.1016/j.ejso.2012.02.180 · Cited by 52
Deschêne, K., Céleste, C., Boerboom, D., & Theoret, C. L. (2011) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2011.09.006 · Cited by 52
uPA/uPAR system activation drives a glycolytic phenotype in melanoma cells
Laurenzana, A., Chillà, A., Luciani, C., Peppicelli, S., Biagioni, A., Bianchini, F., Tenedini, E., Torre, E., Mocali, A., Calorini, L., et al. (2017) · International Journal of Cancer · doi:10.1002/ijc.30817 · Cited by 53
Cleven, A. H. G., van Engeland, M., Wouters, B. G., & A, A. P. D. B. (2007) · Analytical Cellular Pathology · doi:10.1155/2007/945802 · Cited by 52
Svensson, K. J., Welch, J. E., Kucharzewska, P., Bengtson, P., Bjurberg, M., Påhlman, S., ten Dam, G. B., Persson, L., & Belting, M. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-2340 · Cited by 51
Ghorab, M. M., Ragab, F. A.-F., Heiba, H. I., & Soliman, A. M. (2016) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2016.04.009 · Cited by 51
Wirthner, R., Wrann, S., Balamurugan, K., Wenger, R. H., & Stiehl, D. P. (2008) · Carcinogenesis · doi:10.1093/carcin/bgn231 · Cited by 51
RANK-mediated signaling network and cancer metastasis
Chu, G. C., & Chung, L. W. K. (2014) · Cancer and Metastasis Reviews · doi:10.1007/s10555-013-9488-7 · Cited by 50
Design and Synthesis of Novel Small-Molecule Inhibitors of the Hypoxia Inducible Factor Pathway
Mooring, S. R., Jin, H., Devi, N. S., Jabbar, A. A., Kaluz, Š., Liu, Y., Meir, E. G. V., & Wang, B. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm201018g · Cited by 50
Alchera, E., Tacchini, L., Imarisio, C., Ponte, C. D., Ponti, C. D., Gammella, E., Cairo, G., Albano, E., & Carini, R. (2008) · Hepatology · doi:10.1002/hep.22249 · Cited by 50
A tumor hypoxic niche protects human colon cancer stem cells from chemotherapy
Mao, Q., Zhang, Y., Fu, X., Xue, J., Guo, W., Meng, M., Zhou, Z., Mo, X., & Lü, Y. (2012) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-012-1310-3 · Cited by 50
Actuality of Warburg’s views in our understanding of renal cancer metabolism
Godinot, C., de Laplanche, E., Hervouet, É., & Simonnet, H. (2007) · Journal of Bioenergetics and Biomembranes · doi:10.1007/s10863-007-9088-8 · Cited by 49
Imaging of Tumor Hypoxia With Radionuclide-Labeled Tracers for PET
Huang, Y., Fan, J., Li, Y., Fu, S., Chen, Y., & Wu, J. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.731503 · Cited by 53
Prognostic significance of HIF‐1α polymorphisms in transitional cell carcinoma of the bladder
Nadaoka, J., Horikawa, Y., Saito, M., Kumazawa, T., Inoue, T., Narita, S., Yuasa, T., Satoh, S., Nishiyama, H., Ogawa, O., et al. (2007) · International Journal of Cancer · doi:10.1002/ijc.23256 · Cited by 50
Genetic polymorphisms in HIF1A are associated with prostate cancer risk in a Chinese population
Li, P., Cao, Q., Shao, P.-F., Cai, H., Zhou, H., Chen, J., Qin, C., Zhang, Z., Ju, X., & Yin, C. (2012) · Asian Journal of Andrology · doi:10.1038/aja.2012.101 · Cited by 49
Mitochondrial proteomics analysis of tumorigenic and metastatic breast cancer markers
Chen, Y., Chou, H., Lyu, P. C., Yin, H.-S., Huang, F., Chang, W. W., Fan, C., Tu, I., Lai, T.-C., Lin, S., et al. (2011) · Functional & Integrative Genomics · doi:10.1007/s10142-011-0210-y · Cited by 50
Lee, Y.-M., Lim, J.-H., Chun, Y., Moon, H.-E., Lee, M. K., Huang, E. L., & Park, J. (2009) · Carcinogenesis · doi:10.1093/carcin/bgp196 · Cited by 49
The Molecular Mechanism of Metabolic Remodeling in Lung Cancer
Chang, L., Fang, S., & Gu, W. (2020) · Journal of Cancer · doi:10.7150/jca.31406 · Cited by 49
Cancer extracellular vesicles, tumoroid models, and tumor microenvironment
Eguchi, T., Sheta, M., Fujii, M., & Calderwood, S. K. (2022) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2022.01.003 · Cited by 50
Hypoxia inducible factor 1α contributes to regulation of autophagy in retinal detachment
Shelby, S. J., Angadi, P. S., Zheng, Q.-D., Yao, J., Jia, L., & Zacks, D. N. (2015) · Experimental Eye Research · doi:10.1016/j.exer.2015.06.016 · Cited by 51
Kiéda, C., Greferath, R., Silva, C. C. D., Fylaktakidou, K. C., Lehn, J., & Nicolau, C. S. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0607109103 · Cited by 49
Xie, H., Song, J., Liu, K., Ji, H., Shen, H., Hu, S., Yang, G., Du, Y., Zou, X., Jin, H., et al. (2008) · Digestive Diseases and Sciences · doi:10.1007/s10620-008-0296-9 · Cited by 49
Lim, J. S., Shi, Y., Park, S. H., Jeon, S. M., Zhang, C., Park, Y., Liu, R. R., Li, J., Cho, W., Du, L., et al. (2022) · Cell Death and Disease · doi:10.1038/s41419-022-05449-6 · Cited by 49
Cai, X., Huang, Y., Zhang, X., Wang, S., Zou, Z., Wang, G., Wang, Y., & Zhang, Z. (2013) · Gene · doi:10.1016/j.gene.2013.10.048 · Cited by 47
Østergaard, L., Simonsen, U., Eskildsen-Helmond, Y. E. G., Vorum, H., Uldbjerg, N., Honoré, B., & Mulvany, M. J. (2009) · PROTEOMICS · doi:10.1002/pmic.200800130 · Cited by 48
Angiogenic signaling aberrantly induced by tumor hypoxia
Takenaga, K. (2010) · Frontiers in bioscience · doi:10.2741/3674 · Cited by 47
Yu, Y., Hou, L., Huacui, S., Xu, P., Sun, Y., & Wu, K. (2016) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-016-2853-4 · Cited by 49
Xu, G., Li, T., Chen, J., Li, C., Zhao, H., Yao, C., Dong, H., Wen, K., Wang, K., Zhao, J., et al. (2018) · Autophagy · doi:10.1080/15548627.2018.1501251 · Cited by 48
Mitochondria-targeting cyclometalated iridium( iii ) complexes for tumor hypoxic imaging and therapy
Li, J., Chen, H., Zeng, L., Rees, T. W., Xiong, K., Chen, Y., Ji, L., & Chao, H. (2019) · Inorganic Chemistry Frontiers · doi:10.1039/c9qi00081j · Cited by 48
Advances in metabolomics of thyroid cancer diagnosis and metabolic regulation
Abooshahab, R., Gholami, M., Sanoie, M., Azizi, F., & Hedayati, M. (2019) · Endocrine · doi:10.1007/s12020-019-01904-1 · Cited by 48
Multifaceted activities of transcription factor EB in cancer onset and progression
Astanina, E., Bussolino, F., & Doronzo, G. (2020) · Molecular Oncology · doi:10.1002/1878-0261.12867 · Cited by 50
Shapiro, G. I., McCallum, S. W., Adams, L. M., Sherman, L. J., Weller, S., Swann, S., Keer, H. N., Miles, D., Müller, T. R., & LoRusso, P. M. (2012) · Investigational New Drugs · doi:10.1007/s10637-012-9881-z · Cited by 48
Dayan, F., Monticelli, M., Pouysségur, J., & Pécou, E. (2009) · Journal of Theoretical Biology · doi:10.1016/j.jtbi.2009.03.009 · Cited by 48
Self-citationAngiogenesis induction in breast cancer: A paracrine paradigm
Badodekar, N., Sharma, A., Patil, V. R., Telang, G., Sharma, R. K., Patil, S., Vyas, N., & Somasundaram, I. (2021) · Cell Biochemistry and Function · doi:10.1002/cbf.3663 · Cited by 48
Angiogenesis as a strategic target for prostate cancer therapy
Li, Y., & Cozzi, P. J. (2009) · Medicinal Research Reviews · doi:10.1002/med.20161 · Cited by 47
Non-hypoxic induction of HIF-3α by 2-deoxy-d-glucose and insulin
Heidbreder, M., Qadri, F., Jöhren, O., Dendorfer, A., Depping, R., Fröhlich, F., Wagner, K. F., & Dominiak, P. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.11.027 · Cited by 46
Mardilovich, K., & Shaw, L. M. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-1152 · Cited by 45
Li, S., Jiang, X., Zheng, R., Zuo, S., Zhao, L., Fan, G., Fan, J., Liao, Y., Yu, X., & Cheng, H. B. (2018) · Chemical Communications · doi:10.1039/c8cc03430c · Cited by 48
Plasma medicine: Opportunities for nanotechnology in a digital age
Liu, D., Szili, E. J., & Ostrikov, K. (2020) · Plasma Processes and Polymers · doi:10.1002/ppap.202000097 · Cited by 46
miR-372inhibits p62 in head and neck squamous cell carcinomain vitroandin vivo
Yeh, L.-Y., Liu, C., Wong, Y., Chang, C., Lin, S., & Chang, K. (2015) · Oncotarget · doi:10.18632/oncotarget.3340 · Cited by 46
Hypoxia-inducible factors and cancer
Calzada, M. J., & del Peso, L. (2007) · Clinical & Translational Oncology · doi:10.1007/s12094-007-0055-y · Cited by 48
Nakamura, J., Kitajima, Y., Kai, K., Hashiguchi, K., Hiraki, M., Noshirο, H., & Miyazaki, K. (2011) · American Journal Of Pathology · doi:10.1016/j.ajpath.2010.10.010 · Cited by 45
Dayan, F., Bilton, R. L., Laferrière, J., Trottier, E., Roux, D., Pouyssegur, J., & Mazure, N. M. (2009) · Journal of Cellular Physiology · doi:10.1002/jcp.21584 · Cited by 45
Self-citationDiverging prognostic impacts of hypoxic markers according to NSCLC histology
Andersen, S., Eilertsen, M., Dønnem, T., Al-Shibli, K. I., Al‐Saad, S., Busund, L., & Bremnes, R. M. (2010) · Lung Cancer · doi:10.1016/j.lungcan.2010.10.006 · Cited by 45
Ždralević, M., Marchiq, I., de Padua, M. M. C., Parks, S. K., & Pouysségur, J. (2017) · Frontiers in Oncology · doi:10.3389/fonc.2017.00313 · Cited by 45
Self-citationCellular redox status regulates hypoxia inducible factor-1 activity. Role in tumour development.
Martínez-Sánchez, G., & Giuliani, A. (2007) · PubMed · Cited by 45
Guérin, E., Raffelsberger, W., Pencreach, E., Maier, A., Neuville, A., Schneider, A., Bachellier, P., Rohr, S., Petitprez, A., Poch, O., et al. (2012) · Molecular Medicine · doi:10.2119/molmed.2011.00120 · Cited by 44
Knuppertz, L., & Osiewacz, H. D. (2016) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2016.01.003 · Cited by 44
Steinhoff, A., Pientka, F. K., Möckel, S., Kettelhake, A., Hartmann, E., Köhler, M., & Depping, R. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.07.090 · Cited by 44
Antitumor effect of traditional Chinese herbal medicines against lung cancer
Chen, Y., Zhu, J., & Zhang, W. (2014) · Anti-Cancer Drugs · doi:10.1097/cad.0000000000000127 · Cited by 44
Zhang, Y., Wang, H., Zhang, J., Lv, J., & Huang, Y. (2013) · Cancer Science · doi:10.1111/cas.12108 · Cited by 44
Aounallah, M., Dagenais-Lussier, X., Far, M. E., Mehraj, V., Jenabian, M.-A., Routy, J., & van Grevenynghe, J. (2016) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2016.01.001 · Cited by 44
RPS7 inhibits colorectal cancer growth via decreasing HIF-1α-mediated glycolysis
Zhang, W., Tong, D., Liu, F., Li, D., Li, J., Cheng, X., & Wang, Z. (2015) · Oncotarget · doi:10.18632/oncotarget.6807 · Cited by 45
Transglutaminase-2: evolution from pedestrian protein to a promising therapeutic target
Agnihotri, N., & Mehta, K. (2016) · Amino Acids · doi:10.1007/s00726-016-2320-2 · Cited by 44
Sestrin 2 suppresses cells proliferation through AMPK/mTORC1 pathway activation in colorectal cancer
Wei, J., Fang, M., Fu, Z.-X., Zhang, S., Guo, J., Wang, R., Lv, Z., & Xiong, Y.-F. (2017) · Oncotarget · doi:10.18632/oncotarget.17595 · Cited by 44
Gui, L., Zhou, J., Zhou, L., & Wei, S. (2018) · Journal of Materials Chemistry B · doi:10.1039/c8tb00334c · Cited by 44
Teodori, E., Braconi, L., Bua, S., Lapucci, A., Bartolucci, G., Manetti, D., Romanelli, M. N., Dei, S., Supuran, C. T., & Coronnello, M. (2020) · Molecules · doi:10.3390/molecules25071748 · Cited by 44
Metadata
- Authors
- Pouysségur, J., Dayan, F., & Mazure, N. M.
- Affiliations
- Centre National de la Recherche Scientifique (FR)
- Corresponding author
- Pouysségur, Jacques
- Venue
- Nature
- Published
- 2006-05-24
- Volume
- 441
- Issue
- 7092
- Pages
- 437-443
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2082483448
- Semantic Scholar
- 5bbdcf74ee4cdf263a532b6dbae0b8dd5efb9722
- Cited by
- 1,676
- References
- 104
- Citations by year
- 2026: 19 · 2025: 39 · 2024: 48 · 2023: 75 · 2022: 85 · 2021: 97 · 2020: 87 · 2019: 77 · 2018: 81 · 2017: 68 · 2016: 85 · 2015: 80 · 2014: 103 · 2013: 104 · 2012: 89
- FWCI
- 6.91
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- Ligue Contre le Cancer
- Centre National de la Recherche Scientifique
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Ferroptosis and cancer prognosis
- Keywords
- hypoxia signaling, hypoxia-inducible factor, tumor hypoxia, tumor regression, cancer metabolism, intracellular pH regulation, tumor angiogenesis, glucose metabolism, necrosis, autophagy, cell invasion, cancer therapy, tumor oxygenation
- MeSH terms
- Animals, Humans, Neoplasms, Neovascularization, Pathologic, Oxygen, Protein Kinases, Signal Transduction, Cell Hypoxia, TOR Serine-Threonine Kinases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review